Yes, tirzepatide may reduce oral contraceptive effectiveness during the first 4 weeks after starting the medication and for 4 weeks after each dose increase due to delayed gastric emptying
A baseline assessment with your gastroenterologistincluding recent imaging or endoscopystrengthens the safety conversation and clarifies whether GLP-1 is appropriate for your specific disease phenotype and treatment stage
The active factor was isolated and identified as GHK
It is how the drug builds in your system over weeks, how it interacts with your body unique chemistry, and how long its effects truly persist after you stop injecting
This finely crafted injectable improves immunity, supports liver function + promotes detoxification
To indirectly evaluate the impact of treatment duration, we conducted a sensitivity analysis restricted to patients who received a second tirzepatide prescription between six months and one year after the index date